HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dazoxiben, UK 38,485 and aspirin: duration of effect for preventing thrombotic sudden death in rabbits.

Abstract
The purpose of this study was to compare the effects of dazoxiben (DAZ), UK 38,485 (UK) and aspirin (ASA) in the prevention of thrombotic sudden death in rabbits. In anesthetized male rabbits, sudden death was produced by intravenous administration of 0.75 mg/kg arachidonic acid (AA). AA increased plasma TxB2 levels from 0.20 +/- 0.10 ng/ml to 8.75 +/- 1.79 ng/ml and produced a 42% reduction in the number of circulating platelets. Death occurred in all animals within 5 minutes. Administration of DAZ (8.6 mumole/kg) 15 min before AA prevented the increase in plasma TxB2, the thrombocytopenia and sudden death while pretreatment with DAZ 2 hr before AA did not. The administration of UK (8.6 mumole/kg) 15 min. 4 hrs or 8 hrs before AA resulted in 100%, 67% and 33% survival, respectively. ASA (110 mumole/kg) administered 2 or 24 hrs before AA inhibited the increase in plasma TxB2 and prevented the fall in platelet counts. All animals pretreated with ASA survived. These data demonstrate that DAZ and UK have only a short to moderate duration of action in preventing AA-induced increases in plasma Tx levels and thrombocytopenia.
AuthorsL A Lindsay, R W Olson, Y Sakane, R Ghai, E F Smith 3rd
JournalThrombosis research (Thromb Res) Vol. 43 Issue 2 Pg. 177-86 (Jul 15 1986) ISSN: 0049-3848 [Print] United States
PMID3090734 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Arachidonic Acids
  • Imidazoles
  • dazoxiben
  • Arachidonic Acid
  • dazmegrel
  • Thromboxane B2
  • 6-Ketoprostaglandin F1 alpha
  • Aspirin
Topics
  • 6-Ketoprostaglandin F1 alpha (blood)
  • Animals
  • Arachidonic Acid
  • Arachidonic Acids
  • Aspirin (pharmacology)
  • Imidazoles (pharmacology)
  • Male
  • Rabbits
  • Thrombocytopenia (chemically induced, prevention & control)
  • Thrombosis (chemically induced, prevention & control)
  • Thromboxane B2 (blood)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: